Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
16.88%Net Margin
VS
Market
Sector
Industry
History
$ 14.26Close
$ 8.21 - $ 14.6 52-Week Range
Ticker Information
Ticker
TBPHCompany Name
THERAVANCE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTHERAVANCE BIOPHARMA INC - Net Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TBPH - Net % Historical data
| Date | Net Income Common Stock | Net Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 13.03M | 16.88% | $ 77.2M |
| 3/31/2025 | $ -58.33M | -89.38% | $ 65.27M |
| 12/31/2024 | $ -56.42M | -87.63% | $ 64.38M |
| 9/30/2024 | $ -49.4M | -78.18% | $ 63.19M |
| 6/30/2024 | $ -45.65M | -73.61% | $ 62.02M |
| 3/31/2024 | $ -44.77M | -72.78% | $ 61.51M |
| 12/31/2023 | $ -55.19M | -96.11% | $ 57.42M |
| 9/30/2023 | $ -57.05M | -104.65% | $ 54.51M |
| 6/30/2023 | $ 868.54M | 1694.18% | $ 51.27M |
| 3/31/2023 | $ 875.99M | 1803.67% | $ 48.57M |
Key Performance Insights, Last 5 Years
- THERAVANCE BIOPHARMA INC's latest trailing twelve months (TTM) Net % stands at -345.16%.
- Over the past 5 years, THERAVANCE BIOPHARMA INC's average Net % has been 174.72%.
- The median Net % for THERAVANCE BIOPHARMA INC during this period was -92.75%
- THERAVANCE BIOPHARMA INC reached its highest Net % over the past 5 years at 1803.67%.
- The lowest Net % recorded by THERAVANCE BIOPHARMA INC in the same timeframe -414.54%
THERAVANCE BIOPHARMA INC's Net % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
Definition of Net Margin
[Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.Net Inc. Cmn. / Revenues
(=) Net % Net % for THERAVANCE BIOPHARMA INC is calculated as follows: Net Inc. Cmn. [ $ -285.19M ] / Revenues [ $ 82.63M ]
(=) Net % [ -345.16% ] TBPH - Net Margin, Last 5 years
-414.54%
Minimum
Mar 31, 2021
1803.67%
Maximum
Mar 31, 2023
174.72%
Average
-92.75%
Median
Net % Benchmark AnalysisMarket
The chart above depicts the distribution of Net % for companies in the Total Stock Market. The average Net % of the companies is 4.77% with a standard deviation of 19.84%.
The following table provides additional summary stats:
Net % in the Market:
| filtered constituents | 3.2K |
|---|---|
| min | -64.23% |
| max | 69.74% |
| average | 4.77% |
| median | 5.24% |
| std | 19.84% |